M.A. van 't Hof

No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

OBJECTIVE To investigate mortality, functional capacity, and prognostic factors for mortality in an inception cohort of patients with recently diagnosed RA followed up for up to 10 years. METHODS The observed mortality of this inception cohort with recently diagnosed RA, was analysed in relation to the expected mortality, calculated with the aid of life tables of the general population of the Netherlands (matched for age and sex). Functional capacity was measured by the Health Assessment Questionnaire. Prognostic factors for mortality were analysed multivariately by the Cox proportional hazards model. RESULTS Between January 1985 and April 1997, 622 patients entered the study, and were included in the analysis of mortality. The death rate in the first 10 years of the disease was not significantly different from that of the general population. Fifty five patients from the study group died (16% up to 10 years of follow up). The most commonly reported causes of death were of cardiovascular and respiratory origin. The other causes of death could be classified into cancer, sepsis, amyloidosis, leukaemia, renal insufficiency of unknown cause, perforation of the oesophagus, probably related to the treatment with non-steroidal anti-inflammatory drugs, and pancytopenia during aurothioglucose treatment. Functional capacity improved significantly during the first six years compared with the value at start. Statistically significant predictors for death were age at the start and male sex. CONCLUSIONS In contrast with earlier studies performed, no excess mortality in the first 10 years of an inception cohort of patients with RA was seen. In addition, the functional capacity was relatively constant during the first six years after an initial improvement from baseline. Age at start and male sex were the only statistically significant predictors for death.

Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis

OBJECTIVE To compare four different inception cohorts of patients with early rheumatoid arthritis (RA) with respect to treatment strategies, disease activity, and outcome during a five year follow up period. METHOD Data from cohorts of patients with early RA, with a standardised assessment at least every six months for five years from four different centres, were included in one database. Owing to slight differences in the individual study designs, linearly interpolated values were calculated to complete the standard follow up schedule. RESULTS Despite similar inclusion criteria, significant differences in demographic factors and baseline disease activity were found between the different cohorts. During the follow up an aggressive treatment strategy was followed in the Dutch and Finnish cohort, an intermediate strategy in the British cohort, and a conservative strategy in the Swedish cohort. A significant improvement in disease activity was seen in all cohorts, though the most rapid and striking improvement was seen in those receiving aggressive treatment. This resulted in less radiographic destruction in the long run. CONCLUSION This observational study of cohorts of patients with early RA confirms that early aggressive treatment results not only in a more rapid reduction of disease activity but also in less radiographic progression in the long term.

Acid-Susceptibility of Lesions in Bovine Enamel after Remineralization in the Presence of Fluoride and/or Carbonate

After de- and subsequent remineralization at 0.03 and 1.0 ppm fluoride and either 0, 1, 10, 20 or 25 mM carbonate, artificial lesions in bovine enamel were demineralized again. The amount of secondary demineralization was determined after 15, 30 and 70 h of demineralization by means of quantitative microradiography. The results showed that fluoride incorporated during the remineralization period retards lesion formation during secondary demineralization. Carbonate incorporated during the remineralization period enhances secondary demineralization. An interaction between both ions was observed.

Response criteria for slow acting antirheumatic drugs.

1 Smith M D, Ahern M J, Roberts-Thomson P J. Pulse methylprednisolone therapy in rheumatoid arthritis: Unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis 1990; 49: 265-7. 2 Wong C S, Champion G, Smith M D, et al. Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study. Ann Rheum Dis 1990; 49: 370-2. 3 Vineyard G C, Fadem S Z, Dmochowski J, Carpenter C B, Wilson R E. Evaluation of corticosteroid therapy for acute renal allograft rejection. Surg Gynecol Obstet 1974; 138: 225-9. 4 Gardiner P V G, Griffiths I D. Sudden death after treatment with pulsed methylprednisolone. Br Med 1990; 300: 125. 5 Bocanegra T S, Castaneda M 0, Espinoza L R, Vasey F B, Germain B F. Sudden death after methylprednisolone pulse therapy. Ann Intem Med 1981; 95: 122. 6 Moses R E, McCormick A, Nickey W. Fatal arrhythmia after methylprednisolone therapy. Ann Intem Med 1981; 95: 781-2. 7 Garrett R, Paulus H. Complications of intravenous methylprednisolone pulse therapy. Arthritis Rheum 1980; 23: 677. 8 Liebling M R, Leib E, McLaughlin K, et al. Pulse methylprednisolone in rheumatoid arthritis. A double-blind cross-over trial. Ann Intern Med 1981; 94: 21-6. 9 Hansen T M, Dickmeiss E, Jans H, Hansen T I, Ingemann-Nielsen M, Lorenzen I B. Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis. Ann Rheum Dis 1987; 46: 290-5.